Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $80.2B | $101.6B | $157.1B | $171B | $169.2B | |
| Revenue Growth (YoY) | -9.86% | 26.72% | 54.63% | 8.84% | -1.07% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $459M | $204M | $975M | -$470M | -- | |
| Operating Expenses | -$27.7B | -$19.3B | -$14B | -$17.7B | -$20.2B | |
| Operating Income | $27.7B | $19.3B | $14B | $17.7B | $20.2B | |
| Net Interest Expenses | $3.6B | $8.3B | $17.2B | $18.1B | -- | |
| EBT. Incl. Unusual Items | $27.5B | $18.8B | $12.9B | $17B | $19.8B | |
| Earnings of Discontinued Ops. | $7M | -$231M | -$1M | -$2M | -$3M | |
| Income Tax Expense | $5.5B | $3.6B | $3.5B | $4.2B | $5.4B | |
| Net Income to Company | $21.9B | $15.1B | $9.2B | $12.7B | -- | |
| Minority Interest in Earnings | $73M | $89M | $153M | $151M | $146M | |
| Net Income to Common Excl Extra Items | $21.9B | $15.1B | $9.2B | $12.7B | $14.3B | |
| Basic EPS (Cont. Ops) | $10.21 | $7.04 | $4.07 | $6.03 | $7.11 | |
| Diluted EPS (Cont. Ops) | $10.14 | $7.00 | $4.04 | $5.94 | $6.99 | |
| Weighted Average Basic Share | $2B | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | $2B | $2B | $2B | $1.9B | $1.9B | |
| EBITDA | -- | $48.8B | $95.8B | $111B | -- | |
| EBIT | $35.5B | $44.5B | $91.3B | $106.7B | $102.9B | |
| Revenue (Reported) | $80.2B | $101.6B | $157.1B | $171B | $169.2B | |
| Operating Income (Reported) | $27.7B | $19.3B | $14B | $17.7B | $20.2B | |
| Operating Income (Adjusted) | $35.5B | $44.5B | $91.3B | $106.7B | $102.9B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $19.2B | $31B | $41B | $41.1B | $42.2B | |
| Revenue Growth (YoY) | -0.11% | 61.9% | 32.27% | 0.18% | 2.59% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$100M | $538M | -$168M | -$271M | -- | |
| Operating Expenses | -$4B | -$3.4B | $1.2B | -$4.1B | -$4B | |
| Operating Income | $4B | $3.4B | -$1.2B | $4.1B | $4B | |
| Net Interest Expenses | $907M | $3.5B | $4.6B | $4.4B | $4.5B | |
| EBT. Incl. Unusual Items | $4B | $3.2B | -$2.1B | $3.8B | $3.8B | |
| Earnings of Discontinued Ops. | -- | -$2M | -$1M | -- | -$1M | |
| Income Tax Expense | $771M | $640M | -$296M | $912M | $1.3B | |
| Net Income to Company | $3.2B | $2.5B | -$1.8B | $2.9B | -- | |
| Minority Interest in Earnings | $6M | $21M | $31M | $34M | $51M | |
| Net Income to Common Excl Extra Items | $3.2B | $2.5B | -$1.9B | $2.9B | $2.5B | |
| Basic EPS (Cont. Ops) | $1.47 | $1.16 | -$1.15 | $1.36 | $1.21 | |
| Diluted EPS (Cont. Ops) | $1.46 | $1.16 | -$1.14 | $1.34 | $1.19 | |
| Weighted Average Basic Share | $2B | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | $2B | $2B | $1.9B | $1.9B | $1.8B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6B | $15.6B | $20.5B | $25.1B | $24.8B | |
| Revenue (Reported) | $19.2B | $31B | $41B | $41.1B | $42.2B | |
| Operating Income (Reported) | $4B | $3.4B | -$1.2B | $4.1B | $4B | |
| Operating Income (Adjusted) | $6B | $15.6B | $20.5B | $25.1B | $24.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $80.2B | $104.3B | $157.9B | $170.9B | $170.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $459M | $881M | $1.1B | -$385M | -- | |
| Operating Expenses | -$27.7B | -$21.7B | -$13.8B | -$17.5B | -$20.2B | |
| Operating Income | $27.7B | $21.7B | $13.8B | $17.5B | $20.2B | |
| Net Interest Expenses | $3.6B | $8.3B | $17.2B | $18.1B | $17.4B | |
| EBT. Incl. Unusual Items | $27.5B | $18.8B | $12.9B | $17B | $19.8B | |
| Earnings of Discontinued Ops. | $7M | -$231M | -$1M | -$2M | -$3M | |
| Income Tax Expense | $5.5B | $3.6B | $3.5B | $4.2B | $5.4B | |
| Net Income to Company | $21.9B | $15.1B | $9.2B | $12.7B | -- | |
| Minority Interest in Earnings | $73M | $89M | $153M | $151M | $146M | |
| Net Income to Common Excl Extra Items | $21.9B | $15.1B | $9.2B | $12.7B | $14.3B | |
| Basic EPS (Cont. Ops) | $10.15 | $7.03 | $4.04 | $6.02 | $7.08 | |
| Diluted EPS (Cont. Ops) | $10.09 | $6.99 | $4.00 | $5.94 | $6.97 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $36.4B | $44.5B | $91.3B | $106.7B | $102.9B | |
| Revenue (Reported) | $80.2B | $104.3B | $157.9B | $170.9B | $170.8B | |
| Operating Income (Reported) | $27.7B | $21.7B | $13.8B | $17.5B | $20.2B | |
| Operating Income (Adjusted) | $36.4B | $44.5B | $91.3B | $106.7B | $102.9B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $104.3B | $157.9B | $170.9B | $170.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $881M | $1.1B | -$385M | $130M | -- | |
| Operating Expenses | -$21.7B | -$13.8B | -$17.5B | -$20.2B | -- | |
| Operating Income | $21.7B | $13.8B | $17.5B | $20.2B | -- | |
| Net Interest Expenses | $8.3B | $17.2B | $18.1B | $17.4B | -- | |
| EBT. Incl. Unusual Items | $18.8B | $12.9B | $17B | $19.8B | -- | |
| Earnings of Discontinued Ops. | -$231M | -$1M | -$2M | -$3M | -- | |
| Income Tax Expense | $3.6B | $3.5B | $4.2B | $5.4B | -- | |
| Net Income to Company | $15.1B | $9.2B | $12.7B | $8.1B | -- | |
| Minority Interest in Earnings | $89M | $153M | $151M | $146M | -- | |
| Net Income to Common Excl Extra Items | $15.1B | $9.2B | $12.7B | $14.3B | -- | |
| Basic EPS (Cont. Ops) | $7.03 | $4.04 | $6.02 | $7.08 | -- | |
| Diluted EPS (Cont. Ops) | $6.99 | $4.00 | $5.94 | $6.97 | -- | |
| Weighted Average Basic Share | $7.8B | $7.7B | $7.6B | $7.3B | -- | |
| Weighted Average Diluted Share | $7.9B | $7.8B | $7.8B | $7.5B | -- | |
| EBITDA | $8.6B | $23.3B | $28.4B | $26.2B | -- | |
| EBIT | $44.5B | $91.3B | $106.7B | $102.9B | -- | |
| Revenue (Reported) | $104.3B | $157.9B | $170.9B | $170.8B | -- | |
| Operating Income (Reported) | $21.7B | $13.8B | $17.5B | $20.2B | -- | |
| Operating Income (Adjusted) | $44.5B | $91.3B | $106.7B | $102.9B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $38.2B | $47.6B | $46.4B | $42.3B | $23.7B | |
| Short Term Investments | $279.3B | $238.7B | $245.1B | $221.5B | -- | |
| Accounts Receivable, Net | $54.3B | $54.2B | $53.9B | $50.8B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $975.6B | $1.1T | $1.1T | $1.1T | $1.3T | |
| Property Plant And Equipment | $845M | $26.3B | $31.5B | $33B | $33.3B | |
| Long-Term Investments | $230.7B | $319.1B | $241.2B | $261B | $325.9B | |
| Goodwill | $21.3B | $19.7B | $20.1B | $19.3B | -- | |
| Other Intangibles | $4.5B | $4.4B | $4.4B | $4.5B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.3T | $2.4T | $2.4T | $2.4T | $2.7T | |
| Accounts Payable | $61.4B | $69.2B | $63.5B | $66.6B | $74.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $12B | $21.6B | $17.2B | $19.6B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $731.8B | $740.4B | $782B | $754B | $846.3B | |
| Long-Term Debt | $223.7B | $241.5B | $232.2B | $247.7B | $315.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1T | $2.2T | $2.2T | $2.1T | $2.4T | |
| Common Stock | $31M | $31M | $31M | $31M | $31M | |
| Other Common Equity Adj | -$38.8B | -$47.1B | -$44.8B | -$47.9B | -- | |
| Common Equity | $183B | $182.2B | $187.9B | $190.7B | $192.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $700M | $649M | $798M | $768M | $1.5B | |
| Total Equity | $202.7B | $201.8B | $206.3B | $209.4B | $213.8B | |
| Total Liabilities and Equity | $2.3T | $2.4T | $2.4T | $2.4T | $2.7T | |
| Cash and Short Terms | $541.3B | $580.8B | $506B | $498B | -- | |
| Total Debt | $256.7B | $274B | $278B | $289.6B | $315.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $38.2B | $47.6B | $46.4B | $42.3B | $23.7B | |
| Short Term Investments | $279.3B | $238.7B | $245.1B | $221.5B | -- | |
| Accounts Receivable, Net | $54.3B | $54.2B | $53.9B | $50.8B | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $975.6B | $1.1T | $1.1T | $1.1T | $1.3T | |
| Property Plant And Equipment | $845M | $26.3B | $31.5B | $33B | $33.3B | |
| Long-Term Investments | $230.7B | $319.1B | $241.2B | $261B | $325.9B | |
| Goodwill | $21.3B | $19.7B | $20.1B | $19.3B | -- | |
| Other Intangibles | $4.5B | $4.4B | $4.4B | $4.5B | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $2.3T | $2.4T | $2.4T | $2.4T | $2.7T | |
| Accounts Payable | $61.4B | $69.2B | $63.5B | $66.6B | $74.8B | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $12B | $21.6B | $17.2B | $19.6B | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $731.8B | $740.4B | $782B | $754B | $846.3B | |
| Long-Term Debt | $223.7B | $241.5B | $232.2B | $247.7B | $315.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $2.1T | $2.2T | $2.2T | $2.1T | $2.4T | |
| Common Stock | $31M | $31M | $31M | $31M | $31M | |
| Other Common Equity Adj | -$38.8B | -$47.1B | -$44.8B | -$47.9B | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | $1B | -- | -$3.4B | $1.5B | -- | |
| Minority Interest, Total | $700M | $649M | $798M | $768M | $1.5B | |
| Total Equity | $202.7B | $201.8B | $206.3B | $209.4B | $213.8B | |
| Total Liabilities and Equity | $2.3T | $2.4T | $2.4T | $2.4T | $2.7T | |
| Cash and Short Terms | $541.3B | $580.8B | $506B | $498B | -- | |
| Total Debt | $256.7B | $274B | $278B | $289.6B | $315.8B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $11.1B | $21.9B | $15.1B | $9.2B | $12.7B | |
| Depreciation & Amoritzation | $3.9B | $4B | $4.3B | $4.6B | $4.3B | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $77.2B | $22B | $22.9B | $2.5B | $12.3B | |
| Capital Expenditures | $3.4B | $4.1B | $5.6B | $6.6B | $6.5B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$193.1B | -$85.7B | -$77.3B | -$84.4B | $54.3B | |
| Dividends Paid (Ex Special Dividend) | $5.4B | $5.2B | $5B | $5.2B | $5.2B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $76.5B | $70.7B | $104.7B | $65.8B | $99.1B | |
| Long-Term Debt Repaid | -$63.4B | -$75B | -$57.1B | -$65B | -$93B | |
| Repurchase of Common Stock | $4.4B | $11.4B | $3.3B | $6.1B | $7.5B | |
| Other Financing Activities | -$411M | -$337M | -$344M | -$329M | -$454M | |
| Cash From Financing | $233.6B | $17.3B | $137.8B | $687M | -$38.3B | |
| Beginning Cash (CF) | $193.9B | $309.6B | $262B | $342B | $260.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $115.7B | -$47.6B | $80B | -$81.1B | $15.6B | |
| Ending Cash (CF) | $309.6B | $262B | $342B | $260.9B | $276.5B | |
| Levered Free Cash Flow | $73.7B | $17.9B | $17.3B | -$4.1B | $5.8B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.2B | $2.5B | -$1.8B | $2.9B | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$8.2B | $4.4B | $963M | $7.1B | -- | |
| Capital Expenditures | $1.3B | $2B | $1.8B | $1.7B | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.6B | -$27.6B | -$44.1B | $25.5B | -- | |
| Dividends Paid (Ex Special Dividend) | $1.2B | $1.2B | $1.3B | $1.3B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $16.7B | $19.3B | $13.4B | $20.9B | -- | |
| Long-Term Debt Repaid | -$18.5B | -$10.1B | -$14.7B | -$25.4B | -- | |
| Repurchase of Common Stock | $153M | -- | $3.9B | $968M | -- | |
| Other Financing Activities | -$9M | -$5M | -$5M | -$6M | -- | |
| Cash From Financing | -$50.6B | $66.2B | $45.7B | -$47.3B | -- | |
| Beginning Cash (CF) | $323.8B | $299.6B | $254B | $303.1B | -- | |
| Foreign Exchange Rate Adjustment | -$409M | -$383M | $4.3B | -$11.8B | -- | |
| Additions / Reductions | -$61.8B | $42.4B | $6.9B | -$26.6B | -- | |
| Ending Cash (CF) | $262B | $342B | $260.9B | $276.5B | -- | |
| Levered Free Cash Flow | -$9.5B | $2.5B | -$802M | $5.4B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $21.9B | $15.1B | $9.2B | $12.7B | -- | |
| Depreciation & Amoritzation | $4B | $4.3B | $4.6B | $4.3B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22B | $22.9B | $2.5B | $12.3B | -- | |
| Capital Expenditures | $4.1B | $5.6B | $6.6B | $6.5B | $4.9B | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$85.7B | -$77.3B | -$84.4B | $54.3B | -- | |
| Dividends Paid (Ex Special Dividend) | $5.2B | $5B | $5.2B | $5.2B | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $70.7B | $104.7B | $65.8B | $99.1B | -- | |
| Long-Term Debt Repaid | -$75B | -$57.1B | -$65B | -$93B | -- | |
| Repurchase of Common Stock | $11.4B | $3.3B | $6.1B | $7.5B | -- | |
| Other Financing Activities | -$337M | -$344M | -$329M | -$454M | -- | |
| Cash From Financing | $17.3B | $137.8B | $687M | -$38.3B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$47.6B | $80B | -$81.1B | $15.6B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $17.9B | $17.3B | -$4.1B | $5.8B | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $15.1B | $9.2B | $12.7B | $8.1B | -- | |
| Depreciation & Amoritzation | $1B | $1.1B | $1.1B | $2.1B | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $22.9B | $2.5B | $12.3B | $25.1B | -- | |
| Capital Expenditures | $5.6B | $6.6B | $6.5B | $4.9B | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$77.3B | -$84.4B | $54.3B | -$178.3B | -- | |
| Dividends Paid (Ex Special Dividend) | $5B | $5.2B | $5.2B | $4B | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $104.7B | $65.8B | $99.1B | $67.5B | -- | |
| Long-Term Debt Repaid | -$57.1B | -$65B | -$93B | -$46.3B | -- | |
| Repurchase of Common Stock | $3.3B | $6.1B | $7.5B | $12.3B | -- | |
| Other Financing Activities | -$344M | -$329M | -$454M | -$770M | -- | |
| Cash From Financing | $137.8B | $687M | -$38.3B | $212.8B | -- | |
| Beginning Cash (CF) | $1.1T | $1.2T | $1.1T | $584.9B | -- | |
| Foreign Exchange Rate Adjustment | -$3.4B | $95M | -$12.7B | $11.9B | -- | |
| Additions / Reductions | $80B | -$81.1B | $15.6B | $71.5B | -- | |
| Ending Cash (CF) | $1.2T | $1.1T | $1.1T | $645.8B | -- | |
| Levered Free Cash Flow | $17.3B | -$4.1B | $5.8B | $20.2B | -- | |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $3.8T
P/E Ratio: 35x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.